Last reviewed · How we verify

NCT03873662: BIMOPECA

Biochemical Makers for Outcome After Pediatric out-of Hospital Cardiac Arrest

Terminated Last updated 30 November 2020
What this trial tests

trial testing Blood sample in Out-Of-Hospital Cardiac Arrest in 4 participants. Terminated before completion.

Timeline
17 May 2019
Primary endpoint
31 October 2020
31 October 2020

Quick facts

Lead sponsorBrno University Hospital
StatusTerminated
Study typeOBSERVATIONAL
Enrollment4
Start date17 May 2019
Primary completion31 October 2020
Estimated completion31 October 2020
Sites1 location across Czechia

Drugs / interventions tested

Conditions studied

Sponsor

Brno University Hospital

Who can join

Adults 14 Days to 19, any sex, with Out-Of-Hospital Cardiac Arrest. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This single-center study will validate serum, imaging and clinical markers to determine outcome of pediatric patients early after Out-of-Hospital cardiac arrest (OHCA). Results are expected to add to the field of postresuscitation care of these children. The validation of markers will provide clinicians with the tools to assess the severity of neurological impairment after hypoxic injury to the brain early after OHCA.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Blood sample

Trials testing the same drug.

Other recruiting trials for Out-Of-Hospital Cardiac Arrest

Currently open trials in the same condition.

Other Brno University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03873662.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing